Ocugen Inc. buy BiotechBee
Start price
26.05.24
/
50%
€1.63
Target price
28.02.26
€3.50
Performance (%)
-49.35%
End price
14.12.24
€0.82
Summary
This prediction ended on 14.12.24 with a price of €0.82. The BUY prediction by BiotechBee for Ocugen Inc. performed very badly with a performance of -49.35%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ocugen Inc. | 1.062% | 1.062% | 155.112% |
| iShares Core DAX® | 4.244% | 2.864% | 14.030% |
| iShares Nasdaq 100 | 4.890% | 2.814% | 32.707% |
| iShares Nikkei 225® | 9.397% | 7.826% | 48.296% |
| iShares S&P 500 | 3.528% | 1.950% | 25.247% |
According to BiotechBee what are the pros and cons of Ocugen Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year